Jennifer Dittman - 20 May 2024 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Signature
/s/ Christopher Murphy, Attorney-in-Fact
Issuer symbol
THRD
Transactions as of
20 May 2024
Net transactions value
-$19,069
Form type
4
Filing time
22 May 2024, 16:36:56 UTC
Previous filing
20 May 2024
Next filing
10 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THRD Common Stock Award $4,481 -1,042 -50% $4.30 1,042 20 May 2024 Direct
transaction THRD Common Stock Sale $14,588 -1,042 -100% $14.00 0 20 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRD Employee Stock Option (right to buy) Options Exercise $0 -1,042 -3.1% $0.000000 32,292 20 May 2024 Common Stock 1,042 $4.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule I 0b5-1 trading plan adopted by the Reporting Person on March 27, 2024.
F2 25% of the total shares vest on December 19, 2023, and thereafter 2.08333% of the total shares uoderlying the award shall vest in equal monthly installmeots uotil fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date